| Date Initiated by Firm | June 25, 2025 |
| Date Posted | August 06, 2025 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-2274-2025 |
| Recall Event ID |
97228 |
| 510(K)Number | K241652 |
| Product Classification |
Multi-target respiratory specimen nucleic acid test including SARS-CoV-2 and other microbial agents - Product Code QOF
|
| Product | DASH SARS-CoV-2 & Flu A/B Test
Model/Catalog Number: SG-0006
combination COVID-19 and Flu test. Each DASH SARS-CoV-2 & Flu A/B Test is individually pouched and labeled. The tests are provided to users in quantities of 10 per kit. Used on the DASH instrument. |
| Code Information |
Lot Code: Lot: BB02
UDI: (01)00850063063036(17)260220(10)BB02
Expiration Date: 20 Feb. 2026
Lot Code: Lot: BB03
UDI: (01)00850063063036(17)260220(10)BB03
Expiration Date: 20 Feb. 2026 |
Recalling Firm/ Manufacturer |
Nuclein LLC 8305 Cross Park Dr Austin TX 78754-5154
|
| For Additional Information Contact | Customer Support +1-888-9923274 |
Manufacturer Reason for Recall | Due to manufacturing error, assay test may result in missed diagnosis or delay of treatment. (Potential false negative result) |
FDA Determined Cause 2 | Process control |
| Action | On June 25, 2025, Nuclein, LLC issued a Urgent: Medical Device Recall notification to affected customers. On July 8, 2025 an updated notification was issued via E.Mail.
a. Review your inventory of DASH SARS-CoV-2 & Flu A/B Tests to confirm the quantity of Lot BB02 or BB03 that you have remaining.
b. Suspend the use and quarantine the affected lot of DASH SARS-CoV-2 & Flu A/B Tests;
Nuclein will replace any unused affected product.
c. Review all results of the product lots detailed in Section 6, below, to identify potentially erroneous diagnosis, except in those cases where alternative confirmation was obtained.
d. Forward this information to all individuals and departments within your organization using the product information detailed in Section 6. If you are not the end user, forward this notice to the product end user.
e. Complete the Acknowledgement and Receipt Form below and either email the completed form to customersupport@nuclein.com or mail to the address identified in the Acknowledgement and Receipt Form.
f. Return the affected tests that you have remaining; Nuclein Customer Support will follow up with you on the details of returning or destroying the affected product. |
| Quantity in Commerce | 710 units |
| Distribution | US distribution to: Florida, New York, Texas, and West Virginia
|
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = QOF
|